# MDT-USD · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** MDT-USD  
**Sources:** 10  
**Published:** 2026-08-17  
**Canonical:** https://app.k3vl4r.com/research/deep-research-mdt-usd-catalysts-narrative-risks-2266

---

# Medtronic (MDT-USD) Research Summary — As of August 17, 2026

## Current Price & Valuation

As of August 17, 2026, Medtronic (MDT) trades at **$91.39** [[6]](https://clearank.com/stock/medtronic-mdt/). The Wall Street consensus 12-month price target stands at **$100.00** across 29 analysts, with a range of $78 to $121 [[5]](https://tickernerd.com/stock/mdt-forecast/)[[6]](https://clearank.com/stock/medtronic-mdt/). MarketBeat reports an average price target of **$98.83** [[1]](https://www.marketbeat.com/stocks/NYSE/MDT/forecast/). CleaRank Financial AI rates the stock as a **Buy** with a fair value estimate of $91.39, suggesting the stock is fairly valued at its current level [[6]](https://clearank.com/stock/medtronic-mdt/).

## Key Recent Catalysts (Last ~1–3 Months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-mdt-usd-catalysts-narrative-risks-2266 (free to sign up)._